BioCentury
ARTICLE | Clinical News

ADI-PEG 20: Phase Ib data

June 27, 2016 7:00 AM UTC

Top-line data from an open-label, U.S. Phase Ib trial in 18 patients with metastatic pancreatic cancer showed that once-weekly intramuscular ADI-PEG 20 plus gemcitabine and Abraxane nab-paclitaxel le...